Summary
Amgen Inc. (AMGN) filed an 8-K on July 25, 2002, to report its earnings for the quarter ended June 30, 2002. The key event is the issuance of a press release on July 24, 2002, detailing the company's financial performance for the period. This filing serves as a direct communication channel for investors to access Amgen's latest financial results and provides an official record of these disclosures. Investors should review the attached press release (Exhibit 99.1) for specific details on revenue, profitability, and any forward-looking statements or strategic updates made by Amgen management. The filing ensures timely dissemination of material information regarding the company's financial health and operational progress.
Key Highlights
- 1Amgen Inc. (AMGN) filed a Current Report (8-K) on July 25, 2002.
- 2The report's primary purpose is to announce Amgen's earnings for the quarter ended June 30, 2002.
- 3The earnings announcement was made via a press release issued on July 24, 2002.
- 4The press release is included as Exhibit 99.1 to the 8-K filing.
- 5The filing incorporates the press release by reference, making it a key part of the official record.
- 6Richard D. Nanula, Executive Vice President, Finance, Strategy and Communications, and Chief Financial Officer, signed the report.